Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Blood Specimen Collection × NET × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 78 Breast 52 Genitourinary 39 Thoracic 33 Gynecologic 26 Head & Neck 25 Dermatologic 18 CNS 18 Tumor-Agnostic 17 Other hematologic neoplasm 16 Myeloid 15 Lymphoid 12 Sarcoma 11 Plasma cell 7 Endocrine 7 Other 5 Other solid neoplasm 3 Other neoplasm 3 NET 1 Classical hematology 1

Conditions

Neuroendocrine Tumors 1

Interventions

lutetium Lu 177 dotatate 6 Magnetic Resonance Spectroscopy 3 Data Collection 3 telotristat ethyl 2 Somatostatin 2 Everolimus 2 Biopsy 2 surufatinib 1 lanreotide 1 copper dotatate CU-64 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sunitinib 1 Sorafenib 1 Salvage Therapy 1 Radionuclide Imaging 1 Radiomics 1 Radiofrequency Ablation 1 Positron-Emission Tomography 1 Plastic Surgery Procedures 1 Phlebotomy 1 Octreotide 1 Lutetium-177 1 Lutetium 1 Liver Transplantation 1 Laparoscopy 1 Electronic Health Records 1 Drug Therapy 1 Diet, Mediterranean 1 Cytidine Triphosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06430021 2025-02-24

PRO-NEM1

Centre Hospitalier Universitaire Dijon

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡